Sympathetic nervous system

advertisement
DYSRHYTMIAS
& Hemodynamic
Monitoring
Cardiac Rhythm Monitoring
 12
lead ECG
 Telemetry
 Halter monitor
 Bedside monitor
 Lead

placement
12 lead
12 lead ECG


Diagnostic
 Structural changes
 Ischemia
 Infarction
 Enlarged cardiac
chambers
 Electrolyte
imbalances
 Drug toxicity
Assessment of
dysrhythmias
 Lead

placement
5 lead
5 lead monitoring




Telemetry monitoring
ICU
Holter monitors
Provides more views in
different leads
 Lead

placement
3 lead
Three Lead



Less lead views
Simple monitoring
Quick
Patch
Considerations

Properly prepare skin
 Clip excessive hair on
the chest wall with
scissors
 Gently rub the skin with
dry gauze
 If skin is oily, wipe with
alcohol first
Heart Anatomy
& Conduction System
Conduction System
Properties of Cardiac Cells

Automaticity


Excitability


Ability to initiate an impulse spontaneously and continuously
Ability to be electrically stimulated
Conductivity

Ability to transmit an impulse along membrane in an orderly
manner

Contractility

Ability to respond mechanically to an impulse
Nervous System Control of the Heart
 Autonomic
nervous system controls:

Rate of impulse formation

Speed of conduction

Strength of contraction
Nervous System Control of the Heart
 Parasympathetic
nerve



nervous system Vagus
Decreases rate
Slows impulse conduction
Decreases force of contraction
Nervous System Control of the Heart
 Sympathetic


nervous system
Increases rate
Increases force of contraction
Intrinsic Rates of the Conduction System
 SA

60-100
 AV

node
node
40-60
 Bundle

of His, Purkinje fibers
20-40
 Ventricles

<20
P Wave



Atrial depolarization
 Firing of SA node
 Should be upright
Normal duration
 0.06-0.12 sec
Source of variation
 Disturbance in atria

PR Interval


Impulse through atria to AV
node, bundle of His
Measured from beginning of
P wave to beginning of QRS
complex
Normal duration


0.12-0.20 sec
Source of variation


Short – impulse from AV
junction
Longer – AV block
QRS Interval


Ventricular Depolarization
Atrial repolarization




Measured from the
beginning to end of QRS
complex
Normal is not always a
traditional wave form
Normal duration


Hidden in wave
< 0.12 sec
Source of variation

Disturbance in bundle
branches or in ventricles
QRS variations
not everyone has “normal” QRS

ST Segment


Time between ventricular
depolarization and
repolarization
Should be flat (isoelectric)
Look for elevation or
depression



Normal duration


ST elevation – myocardial
injury
ST depression – reciprocal
changes and ischemia
0.12 sec
Source of variation



Ischemia
Injury
infarction

T Wave





Ventricular repolarization
Should be upright
Follows QRS complex
Larger than a P wave
Inversion indicates ischemia
to myocardium
Normal duration


0.16 sec
Sources of variation



Electrolyte imbalances
Ischemia
Infarction
QT Interval



Beginning of QRS complex to
end of T wave
Represents time taken for entire
ventricular depolarization and
repolarization
Normal duration


0.34-0.43 sec
Sources of variation



Drugs
Electrolyte imbalances
Changes in heart rate – inverse
relationship

U Wave

Sometimes seen after T wave
??
 May be normal
 May indicate hypokalemia
Rhythm interpretation
A Systematic Approach
Rules for Systematic Interpretation

If the rhythm doesn’t look right check your patient!








Treat the patient not the monitor
Is the rhythm regular or irregular – R to R, then P to P
What is the heart rate
Can you identify P waves
Can you identify QRS complexes & T waves
What is the ratio of P waves to QRS complexes
What is the PR interval
Anything else you notice that shouldn’t be there
Calculating Heart Rate
Regular
Small blocks into 1500
Large blocks into 300
Irregular = 6-second strip
Divide by 300 between waves
Atrial Rhythms

Rhythms that originate in the atria
Normal Sinus Rhythm





Follows normal conduction pattern
Rate
 60-100
P wave
 Normal , one per QRS
PR interval
 Normal, consistent (0.12-0.20)
QRS complex
 Normal (<0.12)
Sinus Bradycardia

ECG characteristics

Rhythm


Rate


Normal, one per QRS
PR interval


<60
P wave


Regular, slow
0.12-0.20, consistent
QRS complex

Normal, <0.12
Sinus Bradycardia
 Clinical




Associations
Normal in fit, athletic individuals
Normal in sleep
Increased vagal tone –e.g. vomiting
Drugs
 Beta
blockers
 Calcium channel blockers




Hypothyroidism
MI
Increased intracranial pressure
Hypoglycemia
Sinus Bradycardia

Clinical significance
 Dependent on patient tolerance
 Symptomatic
 Pale
 Cool skin
 Hypotension
 Weakness
 Angina
 Dizziness
 Syncope
 Confusion or disorientation
 SOB
Sinus Bradycardia
 Treatment



Atropine
Pacemaker
Treat underlying cause
Sinus Tachycardia

ECG characteristics

Rhythm


Rate


Normal, one for every QRS
PR interval


100-200
P wave


Regular, fast
0.12-0.20, consistent
QRS complex

Normal, <0.12
Sinus Tachycardia
 Clinical










Associations
Exercise
Anxiety, pain, fear
Hypotension
Hyperthyroidism
Hypovolemia
Anemia
Hypoxia
Hypoglycemia
MI
Heart failure
Sinus Tachycardia
 Clinical

Associations (cont’d)
Drugs
 Epinephrine
 Norepinephrine
 Atropine
 Caffeine
 Theophylline
 Nifedipine
 Hydralazine
 Sudafed
Sinus Tachycardia
 Clinical


significance
Dependent on tolerance
Symptoms
 Dizziness
 Dyspnea
 Hypotension
 Angina
 Treatment



Treat underlying cause
Vagal maneuvers
Beta blockers
Sinus Arrhythmia

ECG characteristics

Rhythm
Irregular, but with a pattern
 Speeds up with respiration


Rate


P wave


normal
PR interval


60-100
normal
QRS complex

normal
Sinus Arrhythmia
 Clinical
Associations
 Clinical significance
 Treatment
Atrial Fibrillation

ECG characteristics
 Rhythm
 irregular
 Rate
 Atrial 350-600, irregular
 Ventricular - < & > 100 – irregular
 P wave
 Irregular, chaotic
 PR interval
 Not measurable
 QRS complex
 normal
Atrial Fibrillation
 Clinical











Associations
CAD
Rheumatic heart disease cardiomyopathy
Hypertensive heart disease
Heart failure
Pericarditis
Thyrotoxicosis
Alcohol intoxication
Caffeine
Electrolyte disturbances
Stress
Cardiac surgery
Atrial Fibrillation
 Clinical




significance
Most common, clinically significant dysrhythmia
Decreased cardiac output
Thrombus formation
Stroke
 Accounts
for as many as 20% of all strokes
 Treatment






Calcium channel blockers
Beta blockers
Digoxin
Amiodarone
Cardioversion
Anticoagulation therapy
Atrial Flutter

ECG characteristics

Rhythm


Rate




Flutter waves – sawtoothed
More than QRS complexes – may be in a ratio
PR interval


Atrial – 200-350 and regular
Ventricular - < & > 100 – regular or irregular
P wave


May be regular or irregular
Not measurable
QRS complex

Normal
Atrial Flutter
 Clinical











Associations
CAD
HTN
Mitral valve disorders
PE’s
Chronic lung disease
Cor pulmonale
Cardiomyopathy
Hyperthyroidism
Digoxin
Quinidine
Epinephrine
Atrial Flutter
 Clinical



significance
Decrease cardiac output
Heart failure
Increased risk of stroke
 Treatment







Slow ventricular response by increasing AV block
Calcium channel blockers
Beta blockers
Cardioversion
Amiodarone
Rhythmol
Ablation
Supraventricular Tachycardia

ECG characteristics

Rhythm


Rate


Regular
150-220
P wave
Difficult to determine – may be hidden
 Abnormal


PR interval


Normal or shortened
QRS complex

Normal
Supraventricular Tachycardia
 Clinical









Associations
Overexertion
Emotional stress
Deep inspiration
Caffeine
Tobacco
Rheumatic heart disease
Digitalis toxicity
CAD
Cor pulmonale
Supraventricular Tachycardia

Clinical significance


Prolonged episodes may precipitate decreased
cardiac output
Symptoms
Hypotension
 Dyspnea
 Angina


Treatment

Vagal stimulation


Valsalva maneuver
Drugs
Adenosine
 Beta blockers
 Calcium channel blockers


Cardioversion
Asystole
 There
is no electrical activity in the heart
during asystole, therefore there will only
be a flat line on the rhythm strip
Asystole

Clinical Associations




Clinical significance


Advanced cardiac disease
Severe cardiac conduction system disturbance
End stage heart failure
Prolonged arrest, may not be resuscitated
Treatment





CPR with ACLS
Epinephrine
Atropine
Intubation
Transcutaneous temporary pacemaker
Premature Beats
Premature Atrial Contractions (PAC’s)


Beats occur early in the cycle and there is no compensatory pause
ECG characteristics
 Rhythm
 irregular
 Rate
 Dependent on underlying rhythm
 P wave
 Abnormal shape
 PR interval
 Normal
 Will be different than underlying rhythm
 QRS complex
 Normal
Premature Atrial Contractions (PAC’s)
 Clinical












Associations
Can occur normally
Emotional stress
Physical fatigue
Alcohol
Caffeine
Tobacco
CHF
Ischemia
COPD
Hypoxia
Hyperthyroidism
CAD
Premature Atrial Contractions (PAC’s)
 Clinical


significance
In healthy hearts, not significant
Symptoms
 Heart
“skipped” beat
 Palpitations

May be early indication of more serious
dysrhythmias
 Treatment


Reduce stimulants
Beta blockers
Premature Ventricular Contractions (PVC’s)


Beat early in cycle with compensatory pause
ECG characteristics

Rhythm


Rate


No P wave with premature beat
PR interval


Dependent on underlying rhythm
P wave


irregular
none
QRS complex

Wide bizarre, >0.12
Premature Ventricular Contractions (PVC’s)

Bigeminy


Trigeminy



All PVC’s from same source
Look alike
Multifocal



Every third beat is a PVC
Unifocal


Every other beat is a PVC
Different sources of beat
Beats look different
Couplet


Two in a row
Runs will turn into V-tach
Premature Ventricular Contractions (PVC’s)

Clinical Associations















Caffeine
Alcohol
Nicotine
Aminophylline
Epinephrine
Digoxin
Electrolyte imbalances
Hypoxia
Fever
Exercise
Emotional stress
MI
Mitral valve prolapse
Heart failure
CAD
Premature Ventricular Contractions (PVC’s)


Clinical significance
 Usually benign
 May precipitate
 Decreased cardiac output
 Angina
 Heart failure
 Assess apical-radial pulse rate
Treatment
 Treat underlying cause
 Beta blockers
 Procainamide
 Amiodarone
 Lidocaine
Premature Junctional Contractions (PJC’s)


Beat occurs early in cycle and no compensatory pause
ECG characteristics

Rhythm


Rate


May or may not be present – if present will be inverted
PR interval


Dependent on underlying rhythm
P wave


Irregular
Different from underlying rhythm if there at all
QRS complex

normal
Premature Junctional Contractions (PJC’s)
 Clinical

significance &Treatment
Similar to PAC’s
Junctional Rhythms

Originate below atria and above
ventricles
Junctional Rhythm

ECG characteristics
 Rhythm
 regular
 Rate
 40-60
 P wave
 Inverted, may be hidden in QRS complex
 PR interval
 Shortened or missing
 QRS complex
 normal
Accelerated Junctional Rhythm &
Junctional Tachycardia

ECG characteristics
 Rhythm
 regular
 Rate
 60-180
 P wave
 Inverted, may be hidden in QRS complex
 PR interval
 Shortened or missing
 QRS complex
 normal
Junctional Dysrhythmias
 Clinical










Associations
CAD
Heart failure
Cardiomyopathy
Electrolyte imbalances
Inferior MI
Rheumatic heart disease
Digoxin
Amphetamines
Caffeine
Nicotine
Junctional Dysrhythmias
 Clinical


significance
Occur when the SA node has not been
effective
If increases to junctional tachycardia patient
may become hemodynamically unstable
 Treatment





Dependent on tolerance
Atropine
Beta blockers
Calcium channel blockers
Amiodarone
Ventricular Rhythms

Originate in the ventricles
Idioventricular Rhythm

ECG characteristics

Rhythm


Rate


none
PR interval


20-40
P wave


Regular
absent
QRS complex

Wide, bizarre >0.20
Ventricular Tachycardia

ECG characteristics

Rhythm


Rate


none
PR interval


Ventricular rate 150-250
P wave


Regular R to R
none
QRS complex

Wide, bizarre, > 0.12
Ventricular Tachycardia
 Run
of three or more PVC’s
 Clinical Associations








MI
CAD
Significant electrolyte imbalances
Cardiomyopathy
Mitral valve prolapse
Long QT syndrome
Drug toxicity
CNS disorders
Ventricular Tachycardia
 Clinical







significance
Stable – patient has a pulse
Unstable – no pulse
Decreased cardiac output
Hypotension
Pulmonary edema
Decreased cerebral blood flow
Cardio-pulmonary arrest
Ventricular Tachycardia

Treatment











Treat quickly
Identify and treat underlying causes
Procainamide
Sotalol
Amiodarone
Lidocaine
Beta blockers
Magnesium
Dilantin
Cardioversion
CPR & ACLS
Ventricular Fibrillation

ECG characteristics

Rhythm


Rate


No P waves
PR interval


No rate
P wave


No rhythm present
none
QRS complex

none
Ventricular Fibrillation

Clinical associations











Acute MI
Myocardial ischemia
Heart failure
Cardiomyopathy
Cardiac catheterization
Cardiac pacing
Accidental electric shock
Hyperkalemia
Hypoxemia
Acidosis
Drug toxicity
Ventricular Fibrillation
 Clinical

significance
Symptoms
 Unresponsive
 Pulseless
 Apneic

state
If not treated rapidly, patient will die
 Treatment


Immediate CPR & ACLS
Immediate defibrillation
Ventricular Standstill

ECG characteristics

Rhythm


Rate


normal
PR interval


Atria 60-80
P wave


Regular p waves
none
QRS complex

none
Heart Blocks
First Degree AV Block

ECG characteristics

Rhythm


Rate


Normal
PR interval


Normal
P wave


Regular
>0.20
QRS complex

normal
First Degree AV Block
 Clinical








Association
MI
CAD
Rheumatic fever
Hyperthyroidism
Vagal stimulation
Digoxin
Beta blockers
Calcium channel blockers
First Degree AV Block
 Clinical



significance
Usually not serious
Can be a precursor for higher degrees of AV
block
Patients are asymptomatic
 Treatment


No treatment unless caused by medications
Monitor patient for increase in block
Second Degree AV Block – Type I


Also called Mobitz I or Wenckebach
ECG characteristics

Rhythm


Rate



More p waves than QRS complexes
PR interval


Atrial – normal and regular
Ventricular – slightly higher than atrial rate
P wave


Irregular
Progressing lengths until drops QRS
QRS complex

Normal and then one dropped
Second Degree AV Block – Type I

Clinical Association




Clinical significance




Digoxin
Beta blockers
CAD
Myocardial ischemia or infarction
Generally transient and well tolerate
May be warning sign for a more serious AV
disturbance
Treatment

Symptomatic



Atropine
Temporary pacemaker
Asymptomatic


Closely monitored
Transcutaneous pacer on standby
Second Degree AV Block – Type II


Also called Mobitz II
ECG characteristics

Rhythm



Rate



More p waves than QRS complexes, stated in a ratio
PR interval


Atrial – normal and regular
Ventricular – slower, regular or irregular
P wave


Irregular
Regular if consistent conduction ratio
Normal or prolonged
QRS complex

Preceded by two or more P waves
Second Degree AV Block – Type II

Clinical Association





Clinical significance






Rheumatic heart disease
CAD
Anterior MI
Drug toxicity
Often progresses to third degree AV block
Poor prognosis
Decreased cardiac output
Hypotension
Myocardial ischemia
Treatment

Permanent pacemaker
Third Degree AV Block

ECG characteristics

Rhythm



Rate



Normal, more P waves than QRS complexes
PR interval


Atrial 60-100
Ventricular 20-60, dependent on focus
P wave


R-R regular
P-P regular
No relationship between P waves and QRS complexes
QRS complex

Dependent on focus
Third Degree AV Block
 Clinical

Association
Severe heart disease
 CAD
 MI
 Myocarditis
 Cardiomyopathy





Amyloidosis
Scleroderma
Digoxin
Beta blockers
Calcium channel blockers
Third Degree AV Block

Clinical significance







Reduced cardiac output
Ischemia
Heart failure
Shock
Syncope
possible periods of asystole
Treatment





Pacemaker
Atropine
Epinephrine
Dopamine
Calcium chloride
Bundle Branch Blocks
 ECG

characteristics
QRS complex
 Wide,
bizarre
Bundle Branch Blocks
 Clinical
significance
 Treatment
• http://www.skillstat.com/Flash/ECG_Sim_
2004.html
• http://www.nobelprize.org/educational/
medicine/ecg/index.html
• http://www.iphoneappsplus.com/medic
al/instant-ecg--an-electrocardiogramrhythms-interpretation-guide/index.htm
Defibrillation & Cardioversion
Including pacemakers and
implanted cardioverter defibrillator
Lifepak
Can be used as defibrillator, monitor, or
transcutaneous pacer
Defibrillation



The use of a carefully controlled electric shock,
administered either through a device on the
exterior of the chest wall or directly to the
exposed heart muscle, to restart or normalize
heart rhythms.
Most effective method of terminating V-Fib and
pulseless V-Tach
Deliver energy using a monophasic or biphasic
waveform
 Monophasic defibrillators deliver energy in
one direction.
 Biphasic defibrillators deliver energy in two
directions.
 Deliver successful shocks at lower energies
 Fewer post shock ECG abnormalities
Defibrillation
 Output
is measured in joules or watts per
second.
 Recommended energy for initial shocks in
defibrillation


Biphasic defibrillators: First and successive
shocks: 150 to 200 joules
Monophasic defibrillators: Initial shock at
360 joules
Defibrillation
 Indications



Pulseless v-tach
V-fib
Always done as emergent
 Contraindications


Multifocal atrial tachycardia
Digitalis toxicity
Cardioversion
 Restoration
of normal heart rhythm: the
use of an electric shock to convert a
dangerously rapid, fluttering, and
ineffective heartbeat to its normal rhythm
 Synchronized circuit delivers a counter
shock on the R wave of the QRS
 Synchronizer switch must be turned ON
Cardioversion
 Indications

A-fib
 If
unstable or new witnessed onset – may do
without anticoagulation but preferred method
is with anticoagulation three weeks prior
 TEE to rule out blood clots

A-flutter (if unstable)
 Anticoagulation

therapy
Stable V-tach (with pulse)
 If
patient does not respond to medications
 Contraindications

Digitalis toxicity associated tachycardia
Defibrillation & Cardioversion
 Nursing






Considerations
IV access
Airway management equipment
Sedative drugs
Monitor
Be aware of possible implanted devices
Firm pressure when discharging
 Decrease

chance for arcing and burns
Clear of patient and bed
Defibrillation & Cardioversion
 Complications


Hypoxia or hypoventilation from sedation
Burns
 Mostly

superficial some deep tissue
Dysrhythmias
 Premature
beats
 V-fib




Hypotension
Pulmonary edema
Thromboembolization
Myocardial necrosis r/t high energy discharge
ICD’s & Pacemakers
Implantable CardioverterDefibrillators (ICD’s)
A, The implantable
cardioverter-defibrillator (ICD)
pulse generator from
Medtronic, Inc.
B, The ICD is placed in a
subcutaneous pocket over
the pectoralis muscle. A
single-lead system is placed
transvenously from the pulse
generator to the
endocardium. The single lead
detects dysrhythmias and
delivers an electric shock to
the heart muscle.
Indications for ICD
 Spontaneous
sustained v-tach
 Syncope with inducible v-tach/v-fib
during EP study
 At high risk for future life-threatening
dysrhythmias (cardiomyopathy)
 Have survived cardiac arrest
ICD’s
 Consists
of a lead system placed via
subclavian vein to the endocardium
 Battery-powered pulse generator is
implanted subcutaneously
 ICD sensing system monitors the HR and
rhythm and identifies VT or VF.
 Approximately
25 seconds after detecting
VT or VF, ICD delivers <25 joules.
 If
first shock is unsuccessful, ICD recycles
and delivers successive shocks
ICD’S
 ICDs
are equipped with anti-tachycardia
and anti-bradycardia pacemakers.
 Initiate overdrive pacing of
supraventricular and ventricular
tachycardias
 Provide backup pacing for brady
dysrhythmias that may occur after
defibrillation discharges
 Education is extremely important
 Participation in an ICD support group should
be encouraged
Pacemakers
A, A dual-chamber rateresponsive pacemaker
from Medtronic, Inc., is
designed to treat
patients with chronic
heart problems in which
the heart beats too
slowly to adequately
support the body's
circulation needs.
B, Pacing leads in both
the atrium and ventricle
enable a dual-chamber
pacemaker to sense
and pace in both heart
chambers.
Pacemakers
 Used
to pace the heart when the normal
conduction pathway is damaged or
diseased

Pacing circuit consists of a power source,
one or more conducting (pacing) leads,
and the myocardium
Pacemaker types
 Permanent


Single chamber
Dual chamber
 Temporary



Transcutaneous
Transvenous
epicardial
Indications for permanent pacemakers
Indications for a temporary pacemaker
Pacemakers
 Anti-bradycardia
pacing
 Anti-tachycardia pacing: Delivery of a
stimulus to the ventricle to terminate tachydysrhythmias
 Overdrive pacing: Pacing the atrium at rates
of 200 to 500 impulses per minute to
terminate atrial tachycardias
 Permanent pacemaker: Implanted totally
within the body
 Cardiac resynchronization therapy (CRT):
Pacing technique that resynchronizes the
cardiac cycle by pacing both ventricles
Temporary pacemakers
 Temporary
pacemaker: Power source
outside the body

Transvenous
 Leads
threaded through veins to right atrium or
ventricle

Epicardial
 Placed
during cardiac surgery – leads are
passed through the chest wall and can be
attached to an external power source

Transcutaneous
 Placed
one lead on top of chest and one lead
posterior
ICD’s & Pacemakers
 Complications







Infection
Hematoma formation at sites of insertion
Pneumothorax
Failure to sense or capture
Perforation of atrial or ventricular septum by
the pacing lead
Corrosion of leads
Battery depletion
ECG Changes Associated with ACS
ECG changes in ACS
 Ischemia


ST segment depression and/or T wave
inversion
ST segment depression is significant if it is at
least 1 mm (one small box) below the
isoelectric line.
ECG changes in ACS
 Changes
occur in response to the electrical
disturbance in myocardial cells due to
inadequate supply of oxygen.
 Once treated (adequate blood flow is
restored), ECG changes resolve and ECG
returns to baseline
ECG changes in ACS
 Injury

ST segment elevation is significant if >1 mm above
the isoelectric line.
 If
treatment is prompt and effective, may avoid
infarction

If serum cardiac markers are present, an ST-segmentelevation myocardial infarction (STEMI) has occurred.
ECG changes in ACS
 Infarction

Physiologic Q wave is the first negative
deflection following the P wave.
 Small

and narrow (<0.04 second in duration)
Pathologic Q wave is deep and >0.03
second in duration
ECG changes in ACS
 Infarction

Pathologic Q wave indicates that at least
half the thickness of the heart wall is
involved.
 Referred
to as a Q wave MI
 Pathologic Q wave may be present
indefinitely.

T wave inversion related to infarction occurs
within hours and may persist for months
Download